BIOUX
Price
$52.48
Change
+$0.74 (+1.43%)
Updated
Dec 24 closing price
GFACX
Price
$65.80
Change
+$0.76 (+1.17%)
Updated
Dec 24 closing price
Ad is loading...

BIOUX vs GFACX

Header iconBIOUX vs GFACX Comparison
Open Charts BIOUX vs GFACXBanner chart's image
Baron Opportunity R6
Price$52.48
Change+$0.74 (+1.43%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer C
Price$65.80
Change+$0.76 (+1.17%)
VolumeN/A
CapitalizationN/A
BIOUX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BIOUX vs. GFACX commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOUX is a StrongBuy and GFACX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. BIOUX (1.49B). BIOUX (0.00) and GFACX (0.00) have matching dividends . BIOUX was incepted earlier than GFACX: BIOUX (8 years) vs GFACX (24 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. BIOUX (23.29). GFACX has a lower initial minimum investment than BIOUX: GFACX (250) vs BIOUX (5000000). BIOUX annual gain was more profitable for investors over the last year : 39.91 vs. GFACX (19.83). BIOUX return over 5 years is better than : 117.40 vs. GFACX (40.27).
BIOUXGFACXBIOUX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years24 years-
Gain YTD39.53719.636201%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.49B304B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year39.9119.83201%
Returns for 3 years19.41-0.51-3,776%
Returns for 5 years117.4040.27292%
Returns for 10 yearsN/A61.08-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RMNI2.790.06
+2.20%
Rimini Street
APOG72.070.85
+1.19%
Apogee Enterprises
PCG20.220.23
+1.15%
PG&E Corp
DOCS58.270.09
+0.15%
Doximity
CYTH0.60-0.01
-1.13%
Cyclo Therapeutics